Thanks for the ‘Ones’ and ‘Zeros,’ Dr. Gottlieb

Posted by Brian Chapman on March 15, 2019

I admit, the title of this post is an attempt at a ham-fisted connection between the FDA’s impressive, forward-looking digital strategy under Commissioner Scott Gottlieb (as he wraps up his post following his March 5th resignation) and an overall reckoning from his tenure. I also must admit that my assessment has some shortcomings: I watch the FDA from a distance, avoid the political elements and focus only on the medtech industry (drug prices, generic approvals and vaping notwithstanding). Although Jeffrey Shuren, the director of the Center for Devices and Radiological Health, and others at the FDA probably should share credit for many of the positive accomplishments in medtech, the tenure of a leader should be judged by the organization’s accomplishments during that time. As Gottlieb prepares to move on from his role in public service, I’d like to share a few thoughts on the agency’s recent impact on the medtech industry.


>
Read More

Generating Value Through Digital and Connected Health Analytics

Posted by Vishal Srivastava on February 13, 2019

"Digitization" has been disrupting several parts of the economy, including the medical devices industry. Beyond the initial hype, we see several programs beginning to show real results and that look promising for improving quality and decreasing healthcare costs. The industry is beginning to look at digital health solutions to drive differentiation as it moves toward focusing on healthcare value and outcomes.


>
Read More

Five Analytics Trends on the Horizon in Medtech

Posted by Bhargav Mantha on January 31, 2019

Maria Kliatchko co-wrote this blog post with Bhargav Mantha.

With the holidays well behind us, it’s time to take stock of 2018 and discuss what’s ahead for 2019 and beyond. In the past few years, advanced analytics has become much more accessible for many non-tech companies, driven by cheaper storage and improved processing power. Healthcare and the life sciences industries, in particular, are now seeing a lot of interest in the growing volumes of healthcare data, along with increased demand in outcomes-based product design and commercialization from regulators, customers and communities.


>
Read More